Journal article
Subcutaneous Immunoglobulin Therapy for Hypogammaglobulinemia Secondary to Malignancy or Related Drug Therapy
Transfusion Medicine Reviews, Vol.31(1), pp.45-50
2017
Abstract
Immunoglobulin replacement therapy (IRT) has an important role in minimising infections and improving the Health Related Quality of Life (HRQoL) in patients with immunodeficiency, who would otherwise experience recurrent infections. These plasma derived products are available as intravenous immunoglobulin (IVIg) or subcutaneous immunoglobulin (SCIg). The global demand for these products is growing rapidly and has placed pressure on supply. Some malignancies and their treatment (as well as other medical therapies) can lead to secondary hypogammaglobulinaemia or secondary immunodeficiency (SID) requiring IRT. While IVIg use in this cohort has well established therapeutic benefits, little is known about SCIg use. A literature search in June 2015 found only seven published manuscripts on SCIg use. These papers found that both IRT modes had equivalent efficacy in regards to reduction of bacterial infections. In addition, SCIg was reported to produce higher serum IgG trough levels compared to IVIg on equivalent dosage with the added benefit of fewer side effects. Patient HRQoL reports demonstrate preference for SCIg, because of reduced side effects and hospital visits. There are no Health Economic models published on SCIg use in SID, but models on primary immunodeficiency disease and IRT conclude that SCIg provided greater economic benefits than IVIg. The findings of this small number of reports suggest that SCIg therapy for patients with SID is likely to be beneficial for both the patient and healthcare providers. To substantiate wider use of SCIg in SID, larger and more detailed studies are needed to accurately quantify the effectiveness of SCIg.
Details
- Title
- Subcutaneous Immunoglobulin Therapy for Hypogammaglobulinemia Secondary to Malignancy or Related Drug Therapy
- Authors
- Tanja Windegger (Author) - University of the Sunshine Coast - Faculty of Science, Health, Education and EngineeringChristine A Lambooy (Author) - University of the Sunshine Coast - Faculty of Science, Health, Education and EngineeringLeanne Hollis (Author) - University of the Sunshine Coast - Faculty of Science, Health, Education and EngineeringKaren Morwood (Author) - Sunshine Coast Hospital and Health ServiceHelen Weston (Author) - Sunshine Coast Hospital and Health ServiceYoke Lin Fung (Author) - University of the Sunshine Coast - Faculty of Science, Health, Education and Engineering
- Publication details
- Transfusion Medicine Reviews, Vol.31(1), pp.45-50
- Publisher
- W.B. Saunders Co.
- Date published
- 2017
- DOI
- 10.1016/j.tmrv.2016.06.006
- ISSN
- 0887-7963
- Copyright note
- Copyright © 2017. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
- Organisation Unit
- School of Health - Biomedicine; University of the Sunshine Coast, Queensland; School of Health and Sport Sciences - Legacy; School of Nursing, Midwifery and Paramedicine - Legacy; School of Health and Behavioural Sciences - Legacy
- Language
- English
- Record Identifier
- 99450545902621
- Output Type
- Journal article
Metrics
143 File views/ downloads
1143 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Web Of Science research areas
- Hematology
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites